rss
Evid Based Med 2002;7:139 doi:10.1136/ebm.7.5.139
  • Therapeutics

A lifestyle intervention or metformin prevented or delayed the onset of type 2 diabetes in people at risk


 
 QUESTION: In overweight people with increased fasting and postload plasma glucose concentrations, does an intensive lifestyle intervention or treatment with metformin plus standard lifestyle recommendations prevent or delay the onset of type 2 diabetes mellitus?

Design

Randomised (allocation concealed*), blinded (clinicians and participants for metformin and placebo),* placebo controlled trial with mean follow up of 2.8 years.

Setting

27 centres in the US.

Participants

3234 participants (mean age 51 y, 68% women) without diabetes who had a body mass index ≥24 (≥22 for Asians) and a plasma glucose concentration of 5.3 to 6.9 mmol/l in the fasting state and 7.8 to 11.0 mmol/l 2 hours after a 75 g oral glucose load. Exclusion criteria included medications known to alter glucose tolerance and illnesses that could seriously reduce life …

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.